Brief: Timber Pharmaceuticals Announces First Quarter 2022 Financial Results
12/05/2022 21:49
May 12 (Reuters) - Timber Pharmaceuticals Inc TMBR.A :
* TIMBER PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
ANNOUNCES
FIRST QUARTER 2022 FINANCIAL RESULTS
* TIMBER PHARMACEUTICALS - QTRLY LOSS PER SHARE $0.05
Source text for Eikon: ID:nGNX1D30HN
Further company coverage: TMBR.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trex Wind-Down
See all newsBrief: NYSE American To Suspend Trading Immediately In Timber Pharma
Brief: Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business
Brief: NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals
Brief: Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement
Brief: Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing